Medigene AG

Patent Applications and Registrations

Patent applications and USPTO patent grants for Medigene AG.The latest application filed is for "mutated parvovirus structural proteins as vaccines".

Company Profile

7.46.43

Medigene AG - Planegg/Martinsried DE
MediGene AG - Martinsried DE
MEDIGENE AG - Planegg N/A DE
MediGene AG - Deutsches Krebsforschungszentrum Stiftung des of
MediGene AG - Planegg/Martinsreid DE
Medigene AG - Muenchen-Martinsried DE
MEDIGENE AG - LOCHHAMER STRASSE 11 PLANEGG/MARTINSRIED DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3 Grant 11,267,847 - Sonntag , et al. March 8, 2	2022-03-08
Mutated structural protein of a parvovirus Grant 10,822,378 - Lux , et al. November 3, 2	2020-11-03
Mutated Parvovirus Structural Proteins As Vaccines App 20200191788 - BUENING; Hildegard ; et al.	2020-06-18
Assembly Activating Protein (aap) And Its Use For The Manufacture Of Parvovirus Particles Essentially Consisting Of Vp3 App 20200087352 - SONNTAG; Florian ; et al.	2020-03-19
Medicament For The Treatment Of Viral Skin And Tumour Diseases App 20200054552 - CHANG; Yunik ; et al.	2020-02-20
Mutated parvovirus structural proteins as vaccines Grant 10,408,834 - Buening , et al. Sept	2019-09-10
Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3 Grant 10,344,057 - Sonntag , et al. July 9, 2	2019-07-09
Salt Of Cd80 Antagonist App 20180265514 - Matthews; Ian Richard	2018-09-20
Mutated Structural Protein Of A Parvovirus App 20180066024 - LUX; Kerstin ; et al.	2018-03-08
Anti-HER2 vaccine based upon AAV derived multimeric structures Grant 9,821,043 - Michaelis , et al. November 21, 2	2017-11-21
Medicament for the treatment of viral skin and tumour diseases Grant 9,770,406 - Chang , et al. September 26, 2	2017-09-26
Assembly Activating Protein (aap) And Its Use For The Manufacture Of Parvovirus Particles Essentially Consisting Of Vp3 App 20170226160 - SONNTAG; Florian ; et al.	2017-08-10
Mutated structural protein of a parvovirus Grant 9,624,274 - Lux , et al. April 18, 2	2017-04-18
Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3 Grant 9,464,119 - Sonntag , et al. October 11, 2	2016-10-11
Mutated Parvovirus Structural Proteins As Vaccines App 20160153992 - BUENING; Hildegard ; et al.	2016-06-02
Method of Administering a Cationic Liposomal Preparation App 20160081929 - Mescheder; Axel ; et al.	2016-03-24
Treatment of tumors using specific anti-L1 antibody Grant 9,260,521 - Kelm , et al. February 16, 2	2016-02-16
Method of producing a cationic liposomal preparation comprising a lipophilic compound Grant 9,238,021 - Mundus , et al. January 19, 2	2016-01-19
Method of administering a cationic liposomal preparation Grant 9,233,094 - Mescheder , et al. January 12, 2	2016-01-12
Treatment of Triple Receptor Negative Breast Cancer App 20150359778 - Kliche; Kay-Oliver ; et al.	2015-12-17
Treatment of triple receptor negative breast cancer Grant 9,144,563 - Kliche , et al. September 29, 2	2015-09-29
Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin Grant 9,060,998 - Stockfleth June 23, 2	2015-06-23
Method Of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound App 20140205657 - MUNDUS; Carsten ; et al.	2014-07-24
Treatment Of Tumors Using Specific Anti-l1 Antibody App 20140120117 - Kelm; Daniela ; et al.	2014-05-01
Method of producing a cationic liposomal preparation comprising a lipophilic compound Grant 8,663,606 - Mundus , et al. March 4, 2	2014-03-04
Treatment of tumors using specific anti-L1 antibody Grant 8,580,258 - Kelm , et al. November 12, 2	2013-11-12
Mutated Parvovirus Structural Proteins As Vaccines App 20130288921 - BUENING; Hildegard ; et al.	2013-10-31
Liposomal Formulations Of Lipophilic Compounds App 20130259922 - Haas; Heinrich ; et al.	2013-10-03
Use Of A Polyphenol For The Treatment Of A Cancerous Or Pre-cancerous Lesion Of The Skin App 20130245113 - STOCKFLETH; Eggert	2013-09-19
Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin Grant 8,455,022 - Stockfleth June 4, 2	2013-06-04
Mutated Structural Protein Of A Parvovirus App 20130108658 - LUX; Kerstin ; et al.	2013-05-02
Immunomodulating heterocyclic compounds Grant 8,309,552 - Matthews November 13, 2	2012-11-13
Treatment Of Tumors Using Specific Anti-l1 Antibody App 20120258039 - Gast; Daniela ; et al.	2012-10-11
Assembly Activating Protein (aap) And Its Use For The Manufacture Of Parvovirus Particles Essentially Consisting Of Vp3 App 20120135022 - Sonntag; Florian ; et al.	2012-05-31
Treatment of triple receptor negative breast cancer Grant 8,168,216 - Kliche , et al. May 1, 2	2012-05-01
Solubilisation Method App 20120100067 - Fattler; Ursula ; et al.	2012-04-26
Immuno inhibitory pyrazolone compounds Grant 8,163,757 - Matthews April 24, 2	2012-04-24
Method of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound App 20120087975 - Mundus; Carsten ; et al.	2012-04-12
Treatment of tumors using specific anti-L1 antibody Grant 8,138,313 - Kelm , et al. March 20, 2	2012-03-20
Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation Grant 8,092,807 - Jakobsen , et al. January 10, 2	2012-01-10
Salt Of Cd 80 Antagonist App 20120004237 - MATTHEWS; Richard Ian	2012-01-05
Method of producing a cationic liposomal preparation comprising a lipophilic compound Grant 8,075,913 - Mundus , et al. December 13, 2	2011-12-13
Inhibitors of Fatty Acid Oxidation for Prophylaxis and Treatment of Diseases Related to Mitochondrial Dysfunction App 20110212072 - Henkel; Thomas ; et al.	2011-09-01
Use Of A Polyphenol For The Treatment Of A Cancerous Or Precancerous Lesion Of The Skin App 20110166219 - Stockfleth; Eggert	2011-07-07
Structural protein of adeno-associated virus with modified antigenicity, its production and its use Grant 7,968,340 - Hallek , et al. June 28, 2	2011-06-28
Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors Grant 7,932,253 - Matthews April 26, 2	2011-04-26
Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin Grant 7,910,138 - Stockfleth March 22, 2	2011-03-22
Medicament For The Treatment Of Viral Skin And Tumour Diseases App 20110009481 - Chang; Yunik ; et al.	2011-01-13
Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases App 20110002851 - Haas; Heinrich ; et al.	2011-01-06
Medicament for the treatment of viral skin and tumour diseases Grant 7,858,662 - Chang , et al. December 28, 2	2010-12-28
Liposome Preparation By Single-pass Process App 20100316696 - Wiggenhorn; Michael ; et al.	2010-12-16
Percolative Drying For The Preparation Of Particles App 20100297214 - Haas; Heinrich ; et al.	2010-11-25
Mutated Structural Protein Of A Parvovirus App 20100203083 - Lux; Kerstin ; et al.	2010-08-12
Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system App 20100178243 - Haas; Heinrich ; et al.	2010-07-15
Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction App 20100034796 - Henkel; Thomas ; et al.	2010-02-11
Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases App 20100034749 - Schulze; Brita ; et al.	2010-02-11
Use Of Oncolytic Viruses And Antiangiogenic Agents In The Treatment Of Cancer App 20090317456 - Karrasch; Matthias ; et al.	2009-12-24
Artificially produced, three-dimensional muscle tissue Grant 7,618,452 - Eschenhagen November 17, 2	2009-11-17
Structural Protein Of Adeno-associated Virus With Modified Antigenicity, Its Production And Its Use App 20090253897 - Hallek; Michael ; et al.	2009-10-08
Structural protein of adeno-associated virus with modified antigenicity, its production and its use Grant 7,556,965 - Hallek , et al. July 7, 2	2009-07-07
Papilloma virus truncated L1 protein and fusion protein constructs Grant 7,494,658 - Hallek , et al. February 24, 2	2009-02-24
Structural protein of adeno-associated virus with modified antigenicity, its production and its use Grant 7,252,997 - Hallek , et al. August 7, 2	2007-08-07
Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin App 20070059387 - Stockfleth; Eggert	2007-03-15
Papillomavirus truncated L1 protein and fusion protein constructs Grant 7,182,947 - Hallek , et al. February 27, 2	2007-02-27
Adeno-associated virus vector for boosting immunogenicity of cells Grant 7,001,765 - Maass , et al. February 21, 2	2006-02-21
Papilloma virus truncated L1 protein and fusion protein constructs App 20050249745 - Hallek, Michael ; et al.	2005-11-10
Papillomavirus truncated L1 protein and fusion protein constructs App 20040081661 - Hallek, Michael ; et al.	2004-04-29
Papillomavirus truncated L1 protein and fusion protein constructs Grant 6,649,167 - Hallek , et al. November 18, 2	2003-11-18
Papilloma truncated L1 protein and fusion protein constructs Grant 6,562,351 - Hallek , et al. May 13, 2	2003-05-13
Papilloma virus capsomere vaccine formulations and methods of use App 20020197668 - Hallek, Michael ; et al.	2002-12-26
System for the production of AAV vectors App 20020081709 - Bogedain, Christoph ; et al.	2002-06-27
Papilloma virus capsomere vaccine formulations and methods of use App 20020039584 - Hallek, Michael ; et al.	2002-04-04
Papillomavirus truncated L1 protein and fusion protein constructs Grant 6,352,696 - Hallek , et al. March 5, 2	2002-03-05
System for the production of AAV vectors Grant 6,294,370 - Bogedain , et al. September 25, 2	2001-09-25
Recombinant AAV vector-based transduction system and use of same Grant 6,207,453 - Maass , et al. March 27, 2	2001-03-27
Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells Grant 6,171,597 - Maass , et al. January 9, 2	2001-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.